Total Payments
$1,523
2023 Payments
$481.29
Companies
13
Transactions
64
Medicare Patients
3,218
Medicare Billing
$181,593
Payment Breakdown by Category
Food & Beverage$1,451 (95.3%)
Education$72.00 (4.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,451 | 63 | 95.3% |
| Education | $72.00 | 1 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $560.07 | 25 | $0 (2023) |
| Lilly USA, LLC | $264.28 | 11 | $0 (2023) |
| LEO Pharma Inc. | $155.11 | 6 | $0 (2020) |
| PFIZER INC. | $133.43 | 5 | $0 (2023) |
| Incyte Corporation | $130.91 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $77.68 | 4 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $72.00 | 1 | $0 (2019) |
| GENZYME CORPORATION | $46.08 | 2 | $0 (2019) |
| UCB, Inc. | $18.32 | 1 | $0 (2019) |
| Galderma Laboratories, L.P. | $17.13 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $481.29 | 18 | AbbVie Inc. ($179.74) |
| 2022 | $189.80 | 8 | ABBVIE INC. ($103.41) |
| 2021 | $73.90 | 4 | AbbVie Inc. ($53.80) |
| 2020 | $99.58 | 5 | AbbVie Inc. ($41.87) |
| 2019 | $566.93 | 24 | LEO Pharma Inc. ($138.02) |
| 2018 | $111.88 | 5 | AbbVie, Inc. ($49.88) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: Immunology | ||||||
| 11/29/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.69 | General |
| Category: Immunology | ||||||
| 11/21/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: Immunology | ||||||
| 10/25/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.82 | General |
| Category: Dermatology | ||||||
| 10/18/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $34.13 | General |
| Category: Immunology | ||||||
| 09/05/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: DERMATOLOGY | ||||||
| 07/11/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.12 | General |
| Category: Dermatology | ||||||
| 06/06/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.48 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: DERMATOLOGY | ||||||
| 05/10/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: Immunology | ||||||
| 04/11/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $26.22 | General |
| 04/04/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: IMMUNOLOGY | ||||||
| 03/23/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: DERMATOLOGY | ||||||
| 02/23/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.02 | General |
| Category: Dermatology | ||||||
| 12/22/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: Dermatology | ||||||
| 11/02/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Immunology | ||||||
| 10/25/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2022 | Orthofix Medical, Inc. | Physio-Stim (Device) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Stimulator, Bone Growth, Non-Invasive | ||||||
| 05/11/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.80 | General |
| Category: Dermatology | ||||||
| 02/09/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 868 | 1,480 | $225,571 | $56,373 |
| 2022 | 8 | 705 | 1,205 | $162,479 | $42,233 |
| 2021 | 8 | 755 | 1,465 | $171,265 | $46,128 |
| 2020 | 6 | 890 | 1,617 | $154,991 | $36,860 |
Total Patients
3,218
Total Services
5,767
Medicare Billing
$181,593
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 283 | 345 | $91,440 | $23,110 | 25.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 195 | 234 | $48,204 | $11,183 | 23.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 64 | 66 | $21,648 | $6,528 | 30.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 58 | 64 | $18,816 | $5,643 | 30.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 161 | 659 | $17,793 | $3,654 | 20.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $15,570 | $3,605 | 23.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 50 | 55 | $9,196 | $2,138 | 23.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,904 | $512.18 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 203 | 231 | $54,978 | $14,769 | 26.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 165 | 191 | $39,346 | $9,389 | 23.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 49 | 50 | $16,400 | $5,096 | 31.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 133 | 575 | $15,525 | $3,271 | 21.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 34 | 35 | $10,290 | $3,143 | 30.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 73 | 75 | $11,100 | $2,925 | 26.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $10,726 | $2,695 | 25.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 17 | 17 | $4,114 | $943.45 | 22.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 218 | 260 | $56,768 | $16,703 | 29.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 172 | 205 | $42,230 | $9,417 | 22.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 50 | 54 | $16,755 | $5,298 | 31.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 142 | 767 | $20,709 | $4,358 | 21.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 94 | 99 | $13,248 | $4,072 | 30.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 42 | 43 | $12,004 | $4,020 | 33.5% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 22 | 22 | $4,729 | $1,147 | 24.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $4,822 | $1,112 | 23.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 357 | 399 | $48,678 | $13,339 | 27.4% |
About Dr. Thomas Cooper, M.D
Dr. Thomas Cooper, M.D is a Dermatology healthcare provider based in Wellesley, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932106572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Cooper, M.D has received a total of $1,523 in payments from pharmaceutical and medical device companies, with $481.29 received in 2023. These payments were reported across 64 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,451).
As a Medicare-enrolled provider, Cooper has provided services to 3,218 Medicare beneficiaries, totaling 5,767 services with total Medicare billing of $181,593. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Wellesley, MA
- Active Since 06/28/2005
- Last Updated 11/24/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1932106572
Products in Payments
- SKYRIZI (Biological) $283.20
- TALTZ (Drug) $264.28
- ENSTILAR (Drug) $155.11
- EUCRISA (Drug) $133.43
- OPZELURA (Drug) $130.91
- Humira (Biological) $121.08
- DUPIXENT (Drug) $118.08
- RINVOQ (Biological) $95.62
- Skyrizi (Biological) $60.17
- Sotyktu (Drug) $51.46
- Cimzia (Drug) $18.32
- AKLIEF (Drug) $17.13
- EFUDEX (Drug) $16.82
- Physio-Stim (Device) $16.72
- ILUMYA (tildrakizumab-asmn) injection (Biological) $14.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Wellesley
Dr. Ruth Tedaldi, Md, MD
Dermatology — Payments: $182,132
Dermatology $182,132
Dr. Rebecca Osullivan-Hunnewell, Md, MD
Dermatology — Payments: $9,239
Dermatology $9,239
Madeline Krauss, M.d, M.D
Dermatology — Payments: $7,896
Dermatology $7,896
Pamela Norden, M.d, M.D
Dermatology — Payments: $6,317
Dermatology $6,317
Virginia Moye, Md, Mph, MD, MPH
Dermatology — Payments: $4,809
Dermatology $4,809
Pamela Weinfeld, Md, MD
Dermatology — Payments: $4,749
Dermatology $4,749